The article outlines recent funding rounds for New York City startups, highlighting key deals such as Compyl's $12M Series A for its GRC platform and Canid's $10M Series A for its pediatric vaccine management service. ChemFinity Technologies received $7M for its innovative mineral recovery solutions, while Amperos Health raised $4.2M in Seed funding to enhance healthcare collections through AI. These developments reflect a vibrant ecosystem of investment in innovative technology and healthcare solutions in NYC.
Compyl, an AI-powered platform for managing governance, risk, and compliance (GRC), has raised $12M in Series A funding led by Venture Guides. Founded by Simon Shaddock and Stas Bojoukha in 2017, Compyl has now raised a total of $12M in reported equity funding.
Canid, a pediatric vaccine management platform for pediatricians, has raised $10M in Series A funding led by Telescope Partners. Founded by Pedro Sanchez de Lozada in 2020, Canid has now raised a total of $12.9M in reported equity funding.
ChemFinity Technologies, the company behind a critical mineral recovery solution from mining waste, wastewater, and e-waste, has raised $7M in funding according to a recent SEC filing.
Amperos Health, an AI-powered health care collections automation platform, has raised $4.2M in Seed funding led by Uncork Capital, Neo, and Nebular.
Collection
[
|
...
]